NewLink Genetics Corp (NASDAQ:NLNK) Evaluates IO-Based Combination Therapies Through A New Partnership

NewLink Genetics Corp (NASDAQ:NLNK) has today made an announcement regarding its entry into a clinical partnership agreement with AstraZeneca plc (ADR) (NYSE:AZN). The two business giants will be seeking to evaluate the combination of durvalumab with indoximod along with the standard solution of chemotherapy for persons struggling with metastatic pancreatic cancer. The primary goal for the company’s […]

Shares Dip As Newlink Genetics Corp (NASDAQ:NLNK) Continues Pancreatic Cancer Drug Trial

NewLink Genetics Corp (NASDAQ:NLNK) shares fell by 26% amid the decision of the company to continue the third phase of a study involving the pancreatic cancer treatment drug. Having already missed out on the targeted completion time of the study, the announcement by NewLink Genetics has made the Wall Street analysts skeptical about the progress […]

Ebola Fears: Drug And Suit Makers Up In The Market

Boston, MA 10/13/2014 (wallstreetpr) – The Ebola menace is slowly finding its way in the U.S. after a nurse who cared for an Ebola patient was also diagnosed with the virus. Companies developing cures for the diseases lead by Tekmira Pharmaceuticals Corporation (NASDAQ:TKMR) and Sarepta Therapeutics Inc. (NASDAQ:SRPT) have been on an upward swing. Focus […]

NewLink Genetics Corp (NASDAQ:NLNK) and GlaxoSmithKline plc (ADR) (NYSE:GSK) To Come Out With Vaccines To Treat Ebola

Boston, MA 10/02/2014 (wallstreetpr) – Biopharmaceutical company, NewLink Genetics Corp (NASDAQ:NLNK), and a global healthcare company, GlaxoSmithKline plc (ADR) (NYSE:GSK), are working to develop vaccines to treat Ebola. The product is likely to come out in the first six months of the next year. Ebola virus has been spreading the world over after the latest outbreak […]